Impaired olfaction is a recognised non-motor feature and considered to be a reliable biomarker for assisting with diagnosing Parkinson’s disease (PD). In addition, cardiovascular autonomic dysfunction is increasingly accepted in PD as a major non-motor sign. Assessment of both these non-motor symptoms may increase the detection of PD and thus aid management.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Autonomic Neuroscience: Basic and Clinical
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Received: May 15, 2013
© 2013 Published by Elsevier Inc.